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ABSTRACT
Prostate cancer is now the second leading cause of cancer death in American men.
Since many of the diagnostics either have high false results or risky, it’s important to
have better diagnostics and earlier diagnosis of prostate cancer. Aberrant glycosylation is
a hallmark of cancer. When cancer occurs, aberrant glycosylation occurs, therefore,
glycosylation patterns may provide information about different cancer types and
metastatic potential. In order to study and use these glycosylation patterns, the boronic
acid functionalized synthetic lectins that can interact with glycans have been developed.
The work described here focuses on 1) the structure activities of synthetic lectins (SLs),
especially SL11 which is selected against the prostate cancer cell line PC3, for
developing a structure-activity relationship for the SL11 with both purified glycoproteins
and proteins from prostate cell lines, 2) study the ability of an array of SLs to classify
prostate cancer cell lines and colon cancer cell lines.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
1.0 ABSTRACT
During the onset of cancer, the expression of glycans and glycosylation pattern
will change.1 Cancer-associated glycans contribute to tumor invasion, metastasis, and
angiogenesis.2 So, these patterns can be used to diagnose cancer. Therefore, a boronic
acid functionalized synthetic lectin array has been developed. The array was selected
against purified glycoproteins and they showed a great ability to classify cell lines of
different types. In this chapter, the importance of synthetic lectins, glycans or
glycoproteins in the diagnosis of cancer, the strategy of developing sugar sensor array as
well as the ability of the array to discriminate different cell lines will be explained.
1.1 THE IMPORTANCE OF SYNTHETIC LECTIN
Prostate cancer is the second most common cancer in men in the United States.
It is the second leading cause of death from cancer in men.3 The American Cancer
Society estimated new prostate cancer cases in the United States for 2015 were about
220,800. About 1 in 7 men will be diagnosed with prostate cancer within his lifetime.
Prostate cancer can grow slowly for years without painful symptoms but it can also grow
quickly to become a metastatic disease to endanger a patient’s life. This makes earlier
and better diagnosis very important. Current approaches to diagnose prostate cancer
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include PSA blood test, digital rectal exam, transrectal ultrasound, prostate biopsy etc.4
However, some of these diagnostics sometimes lead to false positive, false negative or
painful symptoms to patients. For example, the PSA blood test can have a false positive
up to 75% according to the American Cancer Society.4 So a better prostate cancer
diagnostic is in great need.
Table 1.1 Common expression of cancer associated glycans on malignant tissues.
Cancer
glycan

Ovary

Pancreas

Blood

Malignant tissue
Breast Colon Brain

Prostate

Skin

Lung

x

X

x

x

x

sLea

X

x

x

x

X

x

x

x

x

x

x

sLe

sTn

x

TF

x

Ley

x

X

x

x

x

x

GloboH

x

X

x

x

x

x

PSA

X

GD2

x

x

x

x

x

GD3

x

x

x

x

x

Fucosyl
GM1
GM2

x
x

X

x

x

x

x

x

x

x

In cells, there is a process adding glycans to proteins which is important in cell
recognition, adhesion, and proliferation.5 This process is called glycosylation. Over 70%
of proteins are glycosylated in cells. Cancer cells frequently display glycans at different
levels or with fundamentally different structures than those observed on normal cells.6
Unusual glycosylation patterns indicate specific diseases such as cancer and serve as
biomarkers in clinical diagnosis.7 One of the well-known examples is the prostate specific
antigen (PSA) from tumor cells, which contains a higher level of fucose and absence of

2

sialic acid compared with PSA from normal cells.8 Cancer associated glycans (CAGs)
can be overexpressed differently among cell types which can provide an opportunity for
cancer diagnosis. While there is no specific CAGs for detection of a single type of cancer
at an early stage, aberrant glycosylation of different glycans could form a pattern that
could be used for cancer diagnosis. For instance, in Table 1.1, sLex is over-expressed in
pancreas, breast, colon, and lung cancer while not on other kinds of cancers. 9 But other
glycans are expressed abnormally for other cancers. So using only one of these aberrant
glycans can not tell what type of cancer it is while by looking at the pattern of different
glycans, we can figure out the specific cancer type.
Lectins are defined as proteins that preferentially recognize and bind carbohydrate
complexes from glycolipids and glycoproteins.10 These could be used to detect the pattern
of glycans of different kinds of cancers at different stages. However, natural lectins are
expensive to obtain and there are not many natural lectins commercially available. In
order to mimic the function of natural lectins, synthetic lectins, boronic acid
functionalized short peptides, were developed. Synthetic lectins are glycan sensors
designed to have a covalent yet reversible interaction between boronic acids and the diols
present on the saccharides.
1.2 BORONIC ACID-DIOL INTERACTION
Boronic acid is well-known to form covalent yet reversible interactions with 1, 2
or 1, 3-diols presented on sugars, as seen in Figure 1.1.11 The boron atom of boronic acid
in its neutral form is a sp2 hybridization atom with 6 valence electrons forming 3 bonds in
a trigonal plane orientation. A vacant p orbital is perpendicular to it, which makes it a
good electron acceptor to fill its open shell and achieve a stable octet state. Therefore,
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boronic acid has a high tendency to react with a Lewis base such as hydroxyl groups.
This interaction empowers boronic acid receptors’ glycan binding capacities and makes
them a class of lectin mimetic. The interaction of boronic acids with cis-1,2- or 1,3-diols
to form five- or six-membered cyclic esters is covalent yet reversible. Boronic acids can
also bind to glycans in multivalent binding that enhances both affinity and selectivity.
The strength of boronic acid binding to saccharides can be adjusted by the relative
position of boronic acid and the multivalent interaction thus boronic acids can
differentiate structurally similar saccharide molecules, rendering boronic-acid based
glycan sensing in biologically relevant scenarios possible.

Figure 1.2 Interaction between boronic acids and cis-diols.

Figure 1.1 Boronic acids and cis-diols interaction.
1.3 MULTIVALENCY AND MONOVALENCY
Carbohydrate and protein interactions are very important since many biological
events such as cell recognition, migration, and apoptosis are mediated by protein–
carbohydrate interactions12. These biological communication processes rely on speciﬁc
adhesion to cell surface carbohydrate epitopes.13 Although the protein-carbohydrate
interactions have so many roles in biological processes, these interactions are very weak,
induced by the weak affinity of saccharides for their protein receptors, lectins; binding
events typically proceed with millimolar to micromolar dissociation constants.14

In

nature, in order to increase the binding affinity between carbohydrates and lectins,

4

multivalent interactions are widely used.15 Multivalency can be understood as the ability
of proteins to bind to multiple binding sites on carbohydrates, making low affinity events
into physiologically relevant affinities to have more than additive affect.16 This is very
important to increase the binding affinity and induce selectivity because when one bond
between a glycan and lectin breaks, the other glycan is still binding to another position on
the lectin so the interaction does not break. On the cell surface or in the cells, there are a
lot of sugar moieties. When disease happens, the sugars will be over, under, or neo-

receptor

ligand

complex

monovalency

multivalency

Figure 1.2 Multivalent and monovalent interaction.
expressed. By synthesizing cancer sensors-synthetic lectins, which can induce
multivalent interaction and have different binding affinities with different sugars, diseases
can be diagnosed. Multivalent interactions and monovalent interactions are shown in
Figure 1.2.
1.4 COMBINATORIAL CHEMISTRY
In previous work, synthetic lectins (SLs) libraries and an SL array have been
made. The SLs in the array were chosen from SL libraries. SL libraries were synthesized
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using the split-and-pool method. Peptides are good scaffolds to make biological sensors.
Resins were divided equally to several vials for coupling the amino acid. After coupling
amino acids and deprotecting, resins were mixed and divided equally to several vials
again. The procedure can be repeated several times until all the desired amino acids are
coupled (Figure 1.3). Each bead contains its unique compound and has thousands of
copies of the same molecules on the same bead. The resulting bead-based library was
then screened against different relevant targets. Fluorescein isothiocyanate (FITC)labeled glycoproteins, including ovalbumin (OVA), bovine submaxillary mucin (BSM),
and porcine stomach mucin (PSM), were incubated with the libraries in the presence of
1% BSA (bovine serum albumin) and 10% glycerol. Microscope was then used to detect
any bright beads. Beads selective or cross reactive with OVA, BSM, or PSM were
observed. These bright beads were manually picked out and sequenced. SL1-SL9 were
selected this way.

Split

Amino Acid, HBTU
DMF, 5% N-Mm,

Pool

20% piperidine
in DMF

Figure 1.3 Split-and-pool combinatorial methods to generate peptide libraries.
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1.5 ARRAY BASED DISCRIMINATION
The enzymes catalyze chemical reactions by binding the substrate to the active site
on the enzyme. The shape of the active site is complementary to the geometric shape of a
substrate molecule, which is similar to the mechanism of a lock and key. Therefore it’s
called a “lock and key” binding mode. In this analogy, the lock is the enzyme and the key
is the substrate. Only the correctly sized key (substrate) fits into the key hole (active
site) of the lock (enzyme). These specific interactions can be mimicked for sensor design.
An array includes receptors to generate fingerprint patterns for each analyte, and does not
require one particular receptor to differentiate between analytes, but depends on the
general response from several receptors for each analyte. This approach of sensing is
inspired by the senses of taste and smell. The taste receptor cells in your taste buds make
the taste sensations-bitter, sweet, sour, etc., so your brain can feel the pattern of the taste
sensations to give a “flavor” of the food you eat. The sensing elements chosen in the
array could be either selectively binding to the analytes with high binding affinity or have
low affinity to the analytes. However, these receptors should have different binding
affinities with the analytes in order for the array to differentiate between analytes. The
response of a single sensor element may not be able to identify the analyte. Instead, the
overall response of the receptors contributes to the formation of a specific pattern to
recognize the analyte, which is also called “pattern-recognition” (Figure 1.4).17 This
approach could be explored to distinguish a variety of different analytes.
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Differential Receptors

Single Analyte Pattern

Read
Out

Figure 1.4 Scheme of cross-reactive receptors array.

1.6 PREVIOUS SYNTHETIC LECTIN ARRAY WORK
It’s well-known that boronic acids can react with the diols on sugars and form
covalent yet reversible interaction with 1, 2 or 1, 3-diols presented on sugars, as seen in
Figure 1.2. Our lab incorporated boronic acids on a peptide backbone to make a synthetic
lectin (SL) array. These SLs contain boronic acid moieties on the peptide backbones that
can bind to the diols on the glycoproteins on cells with different binding affinities thus
could be used to classify healthy and cancerous cells. The array contains SL1-SL9 that
share similar sequences: Ac- RXD*(X)3D*XBBRM-resin (Figure 1.5). The resin our lab
used is Tentagel amino resin. M, R, B and D* represent methionine, arginine, betaalanine and boronic acid functionalized Dab. The Xs are random amino acids depending
on the synthetic lectins.
Our lab used peptide as a backbone and incorporate boronic acids into the side
chain of a diamino-butyric acid (Dab), which is a non-natural amino acid. Both natural
and non-natural amino acids were used in order to increase the diversity of the synthetic
lectins. A synthetic lectin library was made using the “split and pool” method. After the
8

library was synthesized, it was incubated with fluorescently labeled purified
glycoproteins and screened against these labeled purified glycoproteins. The
glycoproteins our lab used were ovalbumin (OVA), porcine submaxillary mucin (PSM)
and bovine submaxillary mucin (BSM). Bovine Serum Albumin (BSA) was selected as a
control protein since it does not have glycans associated with it. These glycoproteins vary
in size, content of carbohydrates and the types of glycans incorporated, thus to select
cross reactive SLs. Ovalbumin is a relatively small N-linked glycoprotein (M.W. 45
KDa), contains 3% carbohydrates (mannose and N-acetylglucosamine) by weight of
protein.18 The PSM and BSM belong to mucins family which are high-molecular weight
glycoproteins.

Figure 1.5 Schematic depiction of a bead-based boronic acid functionalized synthetic
lectin.
Higher fluorescence intensity beads suggest stronger binding. The specific beads
which had higher affinity for particular glycoproteins were termed “hits”. These “hits”
were manually picked out, the SLs are cleaved from the beads, and then MS-MS spectra
was performed to get the sequence of these “hits” by former labmates. The sequences for
the synthetic lectin array that includes synthetic lectins 1 to 9 are listed in Table 1.2.
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Table 1.2 Sequence information of SL1-SL9.
SL Name

Sequence

SL1

Ac-RGD*VTFD*RBBRM

SL2

Ac-RTD*RFLD*VBBRM

SL3

Ac-RSD*VTTD*RBBRM

SL4

Ac-RRD*TQTD*QBBRM

SL5

Ac-RAD*TRVD*VBBRM

SL6

Ac-RTD*NRND*FBBRM

SL7

Ac-RSD*YFTD*QBBRM

SL8

Ac-RTD*YGND*NBBRM

SL9

Ac-RTD*YQVD*ABBRM

1.7 DISCRIMINATION OF CELL LINES
In order to test the ability of SL array to classify cell lines, seven cell lines were
used. These cell lines belong to 3 categories. As shown in Table 1.3, NIH/3T3 is a normal
cell line, whereas HT29, HCT116 and CT-26 belong to cancerous/non-metastatic cell
Table 1.3 Seven cell lines used in the classification.

Cell line

Cell lines

Organism

Cancerous

Mouse

CT-26

colon

Cancerous (˂10%)

Mouse

CT-26-F1

colon

Cancerous (50%)

Mouse

CT-26-FL3

colon

Cancerous (90%)

Human

LOVO

colon

Cancerous (high metastatic)

Human

HT-29

colon

Cancerous (low metastatic)

Human

HCT116

colon

Cancerous (low metastatic)

Mouse

NIH/3T3

embryo

Normal

10

lines, and CT-26-F1, CT-26-FL3 and LoVo are cancerous/metastatic. SL1, 3, 4 and 5
were used to distinguish the 7 cell lines. Membrane proteins and glycoproteins were
prepared and fluorescently labeled with FITC and dialyzed to remove excess FITC.
Fluorescently labeled extracts were collected and their absorbance and fluorescence were
measured. SL1,3,4 and 5 were individually incubated with a 50 fold dilution of each
FITC labeled membrane extract for 6h, and washed with screening buffer. Then the beads
were imaged using the fluorescence microscope and fluorescence intensity was analyzed.
Linear discriminant analysis (LDA) was used to analyze the data. LDA is a statistical
method, which minimizes the variation within a cell type while maximizing the
difference between cell types. Leave-one-out cross-validation was used to estimate the
classification accuracy. Each time one sample point was taken out, the rest of the points
formed a new training set. The classification accuracy was determined by whether or not
the excluded point was classified to the correct cell type group. Seven cell lines were
divided into three categories based on metastatic potential. As shown in Table 1.3,
NIH/3T3 is a normal cell line, whereas HT29, HCT116 and CT-26 belong to
cancerous/non-metastatic cell lines, and CT-26-F1, CT-26-FL3 and LoVo are
cancerous/metastatic. The classification accuracy was 97% (LDA plot shown in Figure
1.6). The results demonstrated that the SL array is capable of distinguishing healthy,
cancerous and metastatic cells.
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A.

4
2

NIH/3T3 ( )
Cancerous/non-metastatic ( ) 0

Cancerous/metastatic ( )
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-4
-6

CT-26 ( )
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-4

-2

0

2

4

6

B.

CT-26-F1 ( )

C.

CT-26-FL3 ( )

HT29 ( )

LoVo ( )

4

2

2
0

0
-2

-2
-4
-6

-4

-2

0

2

4

6

8

-4
-6

-4

-2

0

2

4

6

Figure 1.6 The 2-dimensional LDA plot of the patterns of the SL array to
discriminate cells grouped by metastatic potential.

1.8 CONCLUSION
Aberrant glycosylation occurs as the cancer begins.19 These glycans display a
unique pattern for each cell type, providing the opportunity to detect cancer. Synthetic
lectins (SLs), which are cheap, non-toxic, and easy to synthesize, have drawn much
attention. The peptide backbone of the SLs use various natural and non-natural amino
acids and the boronic acid can form covalent bonds with glycans. So the diversity of SLs
and the interaction between SLs and glycans are guaranteed. The combination of the
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synthetic lectins and the boronic acids provides a great potential for the array to be used
as a sensor (either as a selective sensor or in array format) for identification of
glycosylated molecules. Our lab has been focused on the use of boronic acid based
synthetic lectins as sensors for the past several years. The boronic acid functionalized
sensor array for cancer associated glycans is developed. The SL sensor array is able to
classify healthy, cancerous and highly metastatic cells.
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CHAPTER 2
STRUCTURE ACTIVITY RELATIONSHIP STUDY
2.0 ABSTRACT
In this chapter, the main focus is on the structure-activity relationship of synthetic
lectin 11 (SL11) with proteins. Prostate cancer is now the second leading cause of cancer
death in American men. The American Cancer Society estimated new prostate cancer
cases in the United States for 2015 were about 220,800. About 1 in 38 men will die of it.1
There have been diagnostics for prostate cancer. Main methods include PSA (prostate
specific antigen) blood test, digital rectal exam, biopsy, etc. However, these diagnostics
are not perfect. For instance, PSA test may have a 75% false positive according to
American Cancer Society. Biopsy can be a more accurate method to diagnose prostate
cancer, but the process is painful and it’s possible to cause infection to the patient.
Therefore, it’s important to have better diagnostics and earlier diagnosis of prostate
cancer. Glycosylation is a reaction in which a carbohydrate is attached to a hydroxyl
group or other groups of another molecule. It occurs in biological system. Aberrant
glycosylation occurs during the onset of cancer.2 The glycosylation patterns can indicate
the disease states. As discussed previously in Chapter one, in order to study and use these
glycosylation patterns, a synthetic lectin array has been developed. The array contains
SL1 to SL9. These SLs were selected against purified glycoproteins and they showed a
great ability to classify purified glycoproteins and cell lines of different types.3 Now our
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lab has began to choose synthetic lectins against cell lines. The library generating process
is the same as that of previous described. But this library was screened against both
cancerous and noncancerous cell lines.
The work described here used synthetic lectin 11 (SL11) which was selected
against prostate cancer cell line PC3 as well as a series of mutants of SL11 for developing
a structure-activity relationship of SL11 with both purified glycoproteins and proteins
from prostate cell lines.
2.1 INTRODUCTION
Previous study has shown that the SLs in a SL array were able to effectively
distinguish five structurally similar glycans with 94% accuracy, and seven normal,
cancerous and metastatic colon cancer cell lines, including three isogenic cell lines, with
92% accuracy.3 Although the SL array can discriminate cell lines very well, we still don’t
fully understand what components in the SLs are playing important roles in the binding
with glycoproteins or in discrimination. From the sensor design perspective,
understanding the binding mechanism will provide useful information for the future
sensor design. If we can figure out which structure in the SL can increase binding affinity
and selectivity or which structure is important in the discrimination, we can gradually
improve the SL array towards a better prostate cancer diagnostic.
In the previous study, different components on the SLs were changed to see how these
structures affect binding affinity. Our group4 synthesized SL2 (D*3, 7 A), a mutant of
SL2 (a hit that shows moderate selectivity for ovalbumin) that change boronic acid
functionalized diamino butyric acid (Dab) to alanine in order to explore the SLglycoprotein binding. Compared to SL2, SL2 (D*3, 7 A), which no longer had boronic
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acid on it, had very little association with all the glycoproteins. SL2-BAD was also
synthesized in previous study. SL2-BAD replaced 2-formylphenylboronic acid with
benzaldehyde. Compared with SL2, the absence of boronic acid caused a loss of
selectivity. These initial studies indicated that boronic acid-diol interaction could affect
for SL binding and selectivity. They also mutated charged amino acid like arginine.
According to their study, charged amino acids are also useful for binding. This agreed
well with another previous study.
According to another point mutation study on SL5, positively charged arginine is
important for the binding of SL 5 with colon cancer cell lines, and by adding more
arginine on SL5, the binding affinity between SL5 and colon cancer cell lines increases.
That maybe because that colon cancer cells have abundant negatively charged sugars that
have sialic acid components, which agrees with the facts.5
SL11 was selected against cell lines in previous study by Anna Veldkamp.
RWPE_1 cell line and PC3 cell line were used. RWPE_1 cell line is a healthy prostate
cell line and PC3 cell line is a highly metastatic prostate cell line, which is generated
from bone metastasis cells. A portion of a SL library was incubated with a mixture of
FITC labeled RWPE_1 cell membrane (green under green protein filter) proteins and
Rhodamine labeled PC3 membrane proteins (red under red protein filter). A “hit” was
found, which was bright under red protein filter of microscope while looking like other
beads under green protein filter. That indicated the SL on that bead bound to some
proteins or glycoproteins of PC3 while these proteins were not abundant on RWPE_1.
The “hit” was manually picked out by Anna Veldkamp and Edman degradation was
performed to recover the sequence of SL on the bead. The SL was name SL11. SL11 has
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been used in the discriminant of cell lines and showed a great potential to increase the
classification accuracy of cell lines. Therefore, it’s been an interest of our research. Point
mutation studies of SL11 were explored to determine which amino acid is important for
the binding.
2.2 SYNTHESIS OF SL11 MUTANTS
As mentioned above, point mutation on SL11 was explored to determine which
amino acids are important in the binding between SL11 and the glycoproteins. SL11 was
selected out of the dual dye competitive binding between RWPE_1 and PC3 cell line. It
showed selectivity for PC3 over RWPE_1. A series of mutants were made based on it.
Shown in Table 2.1. D* is the boronic acid functionalized Dab. There are 2phenylboronic acids (2-PBA) on Dabs and the arginine on the first position. The beads
used were Tentagel beads, which had amine groups on the beads. Methionine (M) was
coupled first, followed by arginine (R), beta-alanine (B), and beta-alanine. Then a peptide
synthesizer was used to couple the rest of the amino acids to the beads. Then boronic
acids were coupled on the Dabs and the arginine on the N –terminus. The synthesis of the
SL11 and its mutants was confirmed by MALDI analysis. The corresponding molecular
weight of SL11 is 1751 Da, which is consistent with the calculated value. To see the
structure activity of SL, specially to see the structure activity of charged or “polar” amino
acids, SL11(R8A), SL11(T6A), and SL11(Y4A) were synthesized. Arginine was
replaced by alanine because it has a positively charged group on the side chain and it may
form a salt bridge with negatively charged glycoproteins, such as OVA, BSM, and PSM.
Threonine and tyrosine were replaced by Alanine, too. This is because that there are –OH
groups on the side chain of threonine and tyrosine, and they may form hydrogen bonds
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with glycoproteins.
Table 2.1 SL11 and SL11 mutants.

1

SL11

2-PBA-RLD*YLTD*R-BBRM-resin

2

SL11(R8A)

2-PBA-RLD*YLTD*A-BBRM-resin

3

SL11(T6A)

2-PBA-RLD*YLAD*R-BBRM-resin

4

SL11(Y4A)

2-PBA-RLD*ALTD*R-BBRM-resin

2.3 EFFECT OF AMINO ACID RESIDUES OF SL11 BINDING PURIFIED
GLYCOPROTEINS
The effect of amino acid residues was first explored by incubating the SLs with
purified glycoproteins and proteins. SL11 and the mutants were individually incubated
with 0.1 mg/ml FITC labeled BSA, OVA, BSM, and PSM overnight at room
temperature, and washed with phosphate-buffered saline (PBS). All images were taken
with a Leica MZ 16F microscope and a GFP filter set. The glycoproteins vary in size,
content of carbohydrates and the types of glycans incorporated (Table 2.2). Ovalbuminis
a relatively small N-linked glycoprotein (M.W. 45 KDa).6 It contains 3% carbohydrates
(mannose and N-acetylglycosamine) by weight of protein.7 The mucins families are more
glycosylated and with high molecular weights. They contain more than 50% of
oligosaccharides by weight. The glycans on the mucins are principally attached to serines
and

threonines

via

O-linkages.

BSM

contains

N-acetylgalactosamine,

N-

acetylglucosamine, galactose, and fucose with 56.7% carbohydrates by weight of protein.
Its molecular weight is 400 KDa.8 PSM contains similar carbohydrates with BSM and has
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a molecular weight of 1000 KDa,8 and the content of carbohydrates ranges from 60% to
90% by weight of protein.9 These purified glycoproteins contain complex N-linked and
O-linked glycans, some of which (e.g. sialic acid) are known to be associated with
Table 2.2 Information of purified glycoproteins.
Proteins

Molecular
Weight

Major Associated Carbohydrates

Content of
Carbohydrates

Ovalbumin

45 KDa

Mannose, N-acetylglucosamine

3.2%

Bovine Submaxillary
Mucin (BSM)

400 KDa

Sialic acid, N-acetylgalactosamine,
Galactose, Fructose

＞50%

Porcine Stomach
Mucin (PSM)

1000 KDa

Similar to bovine submaxillary
mucin

60-90%

Carcinoembryonic
Fucose,
Sialic
Galactose,
cancers.
Therefore, these glycoproteins
were
chosen
asacid,
model
glycoproteins50-80%
for proof-of200 KDa
Antigen (CEA)

Mannose, N-acetylglucosamine

concept studies. An additional benefit is that these glycoproteins are inexpensive and
commercially available. MATLAB is used to extract information about fluorescence and
quality of the resin. According to the luminosity, we can know the binding affinity
between SL and the glycoproteins. The results are shown in figure 2.1. The results were
based on 3 measurements and each measurement had around 60-100 replicates. The data
was normalized against each protein with SL11. We can see from SL11 and SL11 (R8A),
charge may play a role in the binding between SLs and glycoproteins. We can see that
once we replaced an arginine by alanine, the binding affinity between the SLs and the
glycoproteins decreased, which indicates charge may help with the binding. According to
the results from SL11 and SL11 (T6A), Hydroxyl groups may also be involved in the
binding. Once we replace threonine by alanine, we see the binding decrease, although not
as big as when we replace the arginine. This may be due to the fact that –OH can form
hydrogen bonds with proteins. But when we change threonine to alanine, we also get rid
of a methyl group, so this potentially reduces the steric hindrance induced by the methyl
20

group. So further experiments need to be done to investigate which structure plays a
bigger role. Amino butyric acid (Abu) has a structure similar to threonine, only without
the –OH. So in further study, SL11 (T6Abu) needs to be made to better control the
variables. Phenyl group may negatively affect the binding according to the comparison of
the results between SL11 and SL11 (Y4A). In a PSM binding study, there was an
increase when we replaced the tyrosine by alanine. But the binding affinity with OVA
decreased after the removal of phenol group. This could mean the OVA has a positive
interaction with the phenyol group on tyrosine. In later study, more mutants like SL11
(Y4F), which replace phenol group to a phenyl group, were made in order to better
control the variables. By combining the data from SL11, SL11 (Y4A), and SL11 (Y4F),
it’s possible for us to have a better understanding of the importance of the phenyl group.
Therefore, charge, hydroxyl group, and phenyl group may play roles in the binding. More

1.2
1.1
1
0.9
0.8
0.7
0.6
BSA

BSM
SL11

SL11(R8A)

OVA
SL11(T6A)

PSM
SL11(Y4A)

Figure 2.1 Structure activity relationship of SL11 with purified glycoproteins.

mutants were later made to figure out how these affect binding affinity between SLs and
glycoproteins.
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2.4 EFFECT OF AMINO ACID RESIDUES OF SL11 BINDING PURIFIED
GLYCOPROTEINS USING MORE MUTANTS
Additional mutants were made to study the activity relationship of SL11 with
purified glycoproteins.

Four more SL11 mutants were made. All the mutants of SL11

and SL11 are shown in table 2.3. L, Y, T, A, F, represent leucine, tyrosine, threonine,
alanine and phenylalanine respectively. Abu is a kind of non-natural amino acid, which
represents amino-butyric acid. SL11 (L5A) and SL11 (L2A) were made to investigate the
steric hindrance induced by leucine, which is a relatively big amino acid. SL11 (Y4F)
was made and by comparing SL11, SL11 (Y4A) and SL11(Y4F), we are able to gain an
insight into the structure activity of tyrosine. By comparing SL11, SL11 (T6A) and SL11
(T6Abu), we are able to gain an insight into the structure activities of threonine.
Table 2.3 SL11 and SL11 mutants.
1
2
3
4
5
6
7
8

SL11
SL11(R8A)
SL11(T6A)
SL11(Y4A)
SL11(L5A)
SL11(L2A)
SL11(Y4F)
SL11(T6Abu)

2-PBA-RLD*YLTD*R-BBRM-resin
2-PBA-RLD*YLTD*A-BBRM-resin
2-PBA-RLD*YLAD*R-BBRM-resin
2-PBA-RLD*ALTD*R-BBRM-resin
2-PBA-RLD*YATD*R-BBRM-resin
2-PBA-RAD*YLTD*R-BBRM-resin
2-PBA-RLD*FLTD*R-BBRM-resin
2-PBA-RLD*YLAbuD*R-BBRM-resin

The SLs were synthesized and confirmed by MALDI-MS analysis. The
corresponding molecular weights of the SLs were consistent with the calculated values.
SL11 and the mutants were individually incubated with 0.1 mg/ml FITC labeled BSA,
OVA, BSM, and PSM overnight, and washed with PBS. All images were taken with a
Leica MZ 16F microscope and a GFP filter set. SL2, SL5 and SL6, which were selected
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against purified glycoproteins, were also used as controls to see if they bind to purified
glycoproteins better than SL11, which is selected against cell lines, and its mutant.
Different from SL11 and its mutants, these SLs have 2 boronic acids instead of 3. The
results are shown in Figure 2.2. The data were normalized against the average of the bead
intensity within each protein.

1.4
1.2
1
0.8
0.6
0.4
0.2
0
BSA

BSM

OVA

PSM

SL11

SL11(R8A)

SL11(T6A)

SL11(Y4A)

SL11(L5A)

SL11(Y4F)

SL11(T6Abu)

SL2

SL5

SL6

SL11(L2A)

Figure 2.2. Structure activity relationship of SL11 and mutants with purified
glycoproteins

Generally speaking, SL2, SL5, and SL6 bind to BSM and PSM better than SL11
and the mutants. That’s maybe because there are some galactose and fucose in BSM and
PSM but are not in OVA and BSA. SL2, SL5, and SL6 may bind to thses glycans better
than SL11 and its mutants, even with less boronic acids. The pattern of binding to all SLs
for BSM is almost the same as the pattern of PSM, which agreed very well with the fact
that BSM and PSM has similar contents. SL11 (R8A) always has reduced binding to
purified glycoproteins and proteins versus SL11. That indicates charge plays a role in the
binding of SLs with glycoproteins an proteins. There is not a significant difference
between SL11 (T6A) and SL11 (T6Abu) with proteins. Also, there is not a significant
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difference between SL11(Y4A) and SL11 (Y4F). These Suggested that phenyl group did
not affect the binding between SLs and purified glycoproteins a lot.
2.5 EFFECT OF AMINO ACID RESIDUES OF SL11 ON CELL MEMBRANE
PROTEINS
RWPE_1 and PC3 were used to study the structure-activity relationships of SLs
with cell membrane extracts. RWPE_1 is a kind of epithelial cell from a 54-year-old
white male donor that was immortalized with a single copy of HPV virus. PC3 is a
metastatic cell line. The same Seven SL11 mutants were used. All the SLs are shown in
table 2.3. Cells were cultured and the membrane proteins were isolated with a membrane
protein kit. The SLs were washed with PBS for 3 times, and pre-blocked with 1% BSA in
PBS with glycerol and then incubated with 0.0002 mg/ml labeled membrane proteins
individually for 6 hours. The beads were then washed with PBS three times and imaged
under a microscope using a GFP filter set. Matlab was used to extract the brightness of
the beads. The brightness indicates the binding affinity of SLs with the proteins.
The results are shown in Figure 2.3. The data were averaged correspondingly and
normalized against SL11. Therefore the SL11 is 0. Generally speaking, the mutants bond
to PC3 better than SL11 and bond to RWPE_1 less than SL11. After the point mutation
of arginine to alanine, the binding affinity with both cell lines did not change much. That
may indicate in prostate cells the sialic acid residue, which has a negative charge is not
abundant. So we didn’t see a decrease in the binding affinity after the mutation of
arginine. When we changed threonine to amino butyric acid, the binding increased more
in PC3 cell line than in RWPE_1, which indicate different cell lines have different
preference with –OH group. This can be well used in the future research to better our
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synthetic array. If we look at SL11 (L5A) and SL11 (L2A), we can find the leucine may
help increase the binding affinity with PC3 while decrease the binding affinity with
RWPE_1. This difference leucine made in different cell lines can be used to better
classify cell lines. And at the same time, both PC3 cell line and RWPE_1 showed the
potential to interact with the aromatic ring, because when the SL11 (T6Abu) and SL11
(Y4F) were replaced by SL11 (T6A) and SL11 (Y4A), the binding decreased.
0.15
0.1
0.05
0
RWPE_1

PC3

-0.05
-0.1

SL11

SL11(R8A)

SL11(T6ABu)

SL11(T6A)

SL11(L5A)

SL11(L2A)

SL11(Y4F)

SL11(Y4A)

Figure 2.3 Structure activity relationship of SL11 and mutants with cell
membrane extract.

2.6 CONCLUSIONS
To investigate the structure activity of SL11, a series of mutants were made. SL11
was the focus of this study because it was selected against cell proteins instead of purified
glycoproteins like OVA, BSM and PSM. Charged amino acids appear to be more
important for binding with purified glycoproteins compared with cell membrane proteins.
That’s possibly because that purified glycoproteins contain more negatively charged
moieties than membranes proteins. Also, SL2, SL5, and SL6 bind to PSM and BSM
better than SL11 and its mutants. That’s maybe because there are some galactose and
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fucose in BSM and PSM but are not in OVA and BSA. SL2, SL5, and SL6 may bind to
these glycans better than SL11 and its mutants. The patterns of BSM and PSM with SLs
are highly similar which agrees well with the fact that BSM and PSM have the same
sugar contents. Generally speaking, the mutants bond to RWPE_1 better than SL11 with
RWPE_1. This study only used one healthy and one metastatic prostate cell lines. Further
studies will be continued using more cell lines and secreted proteins to investigate
structure-activity relationship of SL11with glycoproteins.
2.7 EXPERIMENTAL METHODS
Chemicals
All

amino

acids

and

O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-

phosphate (HBTU) were purchased from Novabiochem Corp. Glycoproteins and FITC
were purchased from Sigma-Aldrich. TentaGel resin (Cat. No. MB-300-002; loading
level 0.25 mmol/g) was purchased from Rapp Polymere. All other chemicals were
purchased and used without further purification.
Microscope Usage
A Leica MZ 16F microscope and a GFP filter set (excitation 450-490 nm; emission filter
500-550 nm) were used to take images, which were analyzed by Malab to obtain
luminosity values afterwards. The luminosity values, which indicate the fluorescent
intensity of the beads tell us the binding intensity. High average luminosity values means
brighter beads, which correspond to strong binders.
General method for synthetic lectin synthesis
Standard Fmoc/HBTU chemistry was used to extend the peptide backbone. The amino
acids had Fmoc protected amines, while reactive side chains of the amino acids protected
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by acid-labile protecting groups. The beads were first soaked in DMF for 10 mins, and an
amino acid, which was pre-activated by HBTU, was added. After tumbling 1 h, the beads
were washed with DMF, methanol and DMF. To remove the Fmoc group, 10 mL 20%
piperidine in DMF was used. The next amino acid was coupled using the same procedure.
All of the SLs used started with the same first four amino acids, BBRM, before
introducing other amino acids. For SL1-SL9, acylated arginine was used to cap the ends.
For SL11 and its series mutants, no acylation was used. Then, 2-Formalphenylboronic
acid was incorporated onto diamino-butyric acid which is a non-natural amino acid.
Incorporation of Phenyl Boronic Acid
Th ivDde protecting groups on Dabs were removed with 10 mL of 5% (v/v) hydrazine
monohydrate in DMF for 3 times. Then, 8 equivalent of 2-Formylphenyl boronic acid
was dissolved in a mixture of 0.2 mL methanol and 9.8 mL DMF and the liquid was
added to the beads along with activated 3Ǻ molecular sieves and tumbled at 37 ºC
overnight. NaBH4 was added and the cap was open for around 0.5 h to let the gas release
and the resin was tumbled at 37 ºC for 4 h, followed by washing with DMF, methanol,
and DMF. Molecular sieves were removed by adding DCM so the beads would flow
while the molecular sieves were still at the bottom. So the beads can be transferred to
another reaction vessel. After the boronic acid moiety was coupled, 10 mL of 95% TFA,
2.5% water, and 2.5% triisopropysilane was added to each SL and the resin was tumbled
for 1 h to deprotect the acid-labile protecting groups. This process was repeated twice.
The resin was then washed with DMF, methanol, and DMF.
Phosphate Buffered Saline (PBS)
Sodium phosphate monobasic (monohydrate) (27.6 g, 200 mmol), sodium phosphate
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dibasic (anhydrous) (28.4 g, 200 mmol) and sodium chloride (35.06 g, 600 mmol) were
dissolved in 4 L of DI water and the pH was adjusted to 7.2-7.3 using 3 M NaOH.
Fluorescent Labeling of Purified Proteins
To prepare the FITC labeled glycoproteins, 50 mg of the purified proteins (e.g. OVA,
BSM, or PSM) was dissolved in 8 mL of 0.5 M carbonate buffer (pH= 9.8) and 4 mg of
FITC was dissolved in 2 mL of DMF. The two solutions were combined together in a 15
mL Falcon tube and tumbled at 37 ºC for an hour. The solution was then transferred to a
10 kDa cut-off dialysis membrane and dialyzed in 0.1 M PBS (pH = 7.2). The dialysis
buffer was changed every 4 hours until dialysis was complete. The concentration of the
FITC-glycoprotein was determined using the Bradford assay.
BCA Assay
A Thermo Scientific BCA kit was purchased from VWR. The protein was suspended in
a small amount of phosphate buffered saline (PBS) and a serial of 2 mg / ml standard
BSA protein was used. The standards as well as the sample were added to a 96 well plate
in triplicate using 10 ul protein per well followed by 200 ul of the reagent from the BCA
kit. The wells were mixed thoroughly placed in an oven for 30 minutes at 37°C. After
thirty minutes that plate was read on a plate reader at 562 nm.
Cell Culture
All supplements and media for RWPE_1 and PC3 cell lines were ordered from VWR.
The complete growth medium used to expand RWPE-1 cells was K-SFM supplemented
with recombinant human Epidermal Growth Factor (rhEGF) and Bovine Pituitary Extract
(BPE). The complete growth medium used to expand PC-3 cells was principally RPMI
1640 and FBS. The cells were grown in T75 flasks at 37°C. Complete growth medium
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was pre-warmed before using by placing into a warm incubator before using. Complete
growth medium was stored at 4°C when not using.
Cell Extracts
Cells were grown to 70%- 80% confluence and scraped. The cells were centrifuged and
collected in a 15 ml Falcon tube. Plasma membrane glycoproteins and proteins were
extracted using the Qiagen Plasma Membrane Protein Kit. FITC in DMF was incubated
with membrane proteins at 37°C for 1 hr. In order to purify the proteins, the solution was
then placed in an Amicon ® 10K centrifuge tube and dialyzed with PBS.
Binding Studies with glycoproteins
Weighed 2 mg of each SL into a centrifuge tube. The SLs were then rinsed with PBS for
10 minutes twice. The PBS was removed and 1% BSA in PBS with 10% glycerol was put
in the tubes and incubated for 15 minutes in order to remove non-specific binding. Then,
0.1mg/ml purified glycoprotein was added to SLs and incubated up to 21 hours at room
temperature under aluminum foil. After incubating the beads were washed three times
with PBS and imaged with a fluorescence microscope, Leica MZ 16F, using a GFP filter
set.
Binding Studies with cell extracts
Weighed 2 mg of each SL into a centrifuge tube. The SLs were then rinsed with PBS for
10 minutes for twice. The PBS was removed and 1% BSA in PBS with 10% glycerol was
put in the tubes and incubated for 15 minutes in order to remove non-specific binding.
The solution was then removed. Then, 0.0002 mg/ml membrane extracts was added to the
SLs and then tumbled for 6 hours at room temperature under aluminum foil. After
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tumbling the beads were washed three times with PBS and imaged with a fluorescence
microscope, Leica MZ 16F, using a GFP filter set.
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CHAPTER 3
CLASSIFICATION STUDY AND STRUCTURE ACTIVITY STUDY
WITH SECRETED PROTEINS
3.0 ABSTRACT
A very important use of synthetic lectins is cancer diagnosis. Therefore they have
been used in the discrimination of cancers of different types. This chapter mainly focuses
on application of our synthetic lectins to classify different cancer types and metastatic
potential. Flow cytometry method was used as a new method to look at the bead
fluorescent intensity, and small polystyrene beads were also used in this study. Besides
using the synthetic lectin (SL) array to classify cancers, we are also interested in the
structure-activity relationships of SLs with secreted proteins. So a structure-activity
relationship was also investigated using secreted protein, which is a meaningful move
that can help us gain an insight into the structure-activity relationship of SLs with
secreted proteins, which can better mimic the proteins in blood in human body.
3.1 INTRODUCTION
Glycans and glycoproteins on the cell surface will be over, under or neoexpressed when the cancer occurs.1 Different cancer types may have different
glycosylation patterns. Therefore different glycosylation patterns can be used for cancer
diagnosis.2-4 Some of them have already been clinically applied. For instance, one widely
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used diagnostic test measures the amount of prostate specific antigen (PSA) in patients’
serum, to monitor the stage of prostate cancer. Unfortunately, the PSA test does not work
so well, with a false positive of 75%.5
The cell surface is complicated and there are a lot of different moieties. Therefore,
it’s difficult to use only one sensor to detect a cancer. So using a SL array is much more
reliable to discriminate different cancer types. Each SL binds to a kind of cell’s proteins
or glycoproteins differently from other SLs, and by combining the data from these SLs,
we can create a pattern of the array which indicates the “flavor” of this type of cancer.
Therefore, no highly specific binding is required to detect a cancer.
A previous SL11 structure activity study with purified glycoproteins and
membrane proteins showed that by changing the peptide sequences, the mutants display
differences in the binding with proteins compared with SL11. Membranes proteins are
“mimics” of tissue samples. Secreted proteins are proteins secreted by cells. Cells release
proteins into the blood stream. Secreted proteins in serum are easier to acquire compared
with those in tissue samples because biopsy do not need to be performed. The process of
taking tissues from patients is painful. Therefore, secreted proteins in serum are good
choices to use for the prostate cancer diagnosis. For cell lines, the secreted proteins in
media are good mimics for serum proteins. So secreted proteins in media were used in
this study.
3.2 SYNTHESIS OF SL11 MUTANTS
Point mutation on SL11 was explored to determine which amino acid is important
in the binding between SL11 and the secreted glycoproteins. SL11 and the same series of
mutants were made as previously discussed in Chapter 2. They are shown in Table 3.1.
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D* is the boronic acid functionalized Dab, a non-natural amino acid. These two Dabs are
on the third and seventh position of the peptide backbone. The Arginine on the N
terminal end was not acylated, therefore, there is one boronic acid on the N terminal end.
Therefore, there are three boronic acids in total on each SL. There are one 2phenylboronic acid (2-PBA) on each Dab and the arginine on the first position. The
synthesis of the peptides was confirmed by MALDI analysis. The sequences of all the
mutants of SL11 and SL11 itself are shown in table 3.1.
Table 3.1 SL11 and SL11 mutants.
1

SL11

2-PBA-RLD*YLTD*R-BBRM-resin

2
3
4
5
6
7
8

SL11(R8A)
SL11(T6A)
SL11(Y4A)
SL11(L5A)
SL11(L2A)
SL11(Y4F)
SL11(T6Abu)

2-PBA-RLD*YLTD*A-BBRM-resin
2-PBA-RLD*YLAD*R-BBRM-resin
2-PBA-RLD*ALTD*R-BBRM-resin
2-PBA-RLD*YATD*R-BBRM-resin
2-PBA-RAD*YLTD*R-BBRM-resin
2-PBA-RLD*FLTD*R-BBRM-resin
2-PBA-RLD*YLAbuD*R-BBRM-resin

3.3 STRUCTURE ACTIVITY RELATIONSHIP OF SL11 WITH PROSTATE CELL
LINES.
In this study, secreted proteins and glycoproteins, which were isolated from the
media, were used. RWPE_1, WPE_1NA22, WPE_1NB14, DU145, and PC3 were used to
study the structure activities of SLs with cell proteins. RWPE_1 is a kind of epithelial cell
from a white male donor that was immortalized with HPV virus, and they are not
invasive.6 It’s a healthy cell line. Neoplastic cell lines WPE1-NA22 and WPE1-NB14
were also used and they were derived from RWPE-1.7 They are lowly metastatic cell
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lines. DU145 and PC3 cell lines are also used in the research. They are highly metastatic
cell lines.8
RWPE_1, WPE_1NA22 and WPE_1NB14 cells were cultured in keratinocyte
serum-free medium (K-SFM) with epidermal growth factor (EGF) and bovine pituitary
extract (BPE). DU145 and PC3 cells were cultured in Rosewell Park Memorial Institute
media (RPMI) with fetal bovine serum (FBS), sodium bicarbonate, antibiotics, Lglutamine, D-glucose, HEPES, and sodium pyruvate. Cells were cultured to around 70%
confluent and starved for 48 hours and then secreted proteins were collected from the
media. The 300 um beads which contained SLs were washed with PBS, and pre-blocked
with 1% BSA in PBS with glycerol and then incubated with 0.0002 mg/ml FITC labeled
secreted proteins individually overnight. The beads were then washed with PBS three
times and imaged under a microscope using a green fluorescent protein (GFP) filter set.
Matlab was used to extract the brightness of the beads. The brightness indicates the
binding affinity of SLs with the proteins.
The results were shown in Figure 3.1. The data were normalized against the
intensity of SL11. When the arginine was replaced to alanine, the binding affinities of SL
with 5 kinds of proteins all decreased. This might be because the negatively charged
glycans like the positively charged arginine. Therefore the replacement of arginine to
alanine reduces the binding affinity. But the decreases are not significant, which indicates
the negatively charged glycans are not abundant in prostate cell lines. Upon replaceing
the tyrosine to phenylalanine, basically getting rid of an –OH, the binding affinities of SL
with most of the proteins increased. But there was not a significant trend when the
aromatic ring was gotten rid of based on the comparison between SL11 (T6Abu) with
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SL11 (T6A) and SL11 (Y4F) with SL11 (Y4A). That indicates there might be some
interactions between the glycans and the aromatic system. For most of the proteins, the
replacement of leucine, a bulky group, increased the binding affinities. So in order to
incur better binding affinity, leucine can be replaced. There is no significant tendency
when replace the threonine to alanine or amino butyric acid.
SL11 and its mutants were also used to classify cell lines. The classification
matrix is shown in Table 3.2. The result showed that SL11 and its mutants could
successfully classify 5 cell lines. The total classification accuracy was 96%. The
jackknifed validation showed a similar result, with a total accuracy of 92%. This showed
SLs’ great ability at classifying cell lines. There were two DU145 samples mistaken as
PC3 and one WPE_1NA22 sample was misclassified as WPE_1NB14. There were also
two WPE_1NB14 samples misclassified as DU145 and PC3. However, these
misclassifications are understandable because WPE_1NA22 are close to WPE_1NB14 in
metastatic potential and WPE_1 NB14 is close to highly metastatic cell lines by
metastatic potential. The total classification accuracy was still decent and the healthy cell
line was grouped very well. Since the 5 cell lines have different metastatic potential.
These cell lines were also classified by their metastatic potential. The
classification matrix was shown in Table 3.3. Healthy cell line was grouped very well
within its category. There were some misclassifications between lowly metastatic cell
lines and highly metastatic cell lines. But the total classification accuracy was very decent
at 95%. The jacknifed classification accuracy, which involves allocating each individual
to its closest group without using it to determine the center of the group, was 94%. The 2
dimensional LDA plot was shown in Figure 3.2. Lowly metastatic samples overlapped
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with highly metastatic samples a little bit. But generally speaking, they were grouped
very well within their categories.

1.4
1.3
1.2
1.1
1
0.9
0.8
0.7
0.6
0.5
RWPE_1
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WPE_1NA22
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SL11(T6A)

WPE_1NB14

SL11(Y4A)

SL11(L5A)

DU145
SL11(L2A)
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SL11(Y4F)

SL11(T6Abu)

Figure 3.1 Activity relationship of SL11 with cell secreted proteins.

Table 3.2 Classification matrix of 5 cell lines.
RWPE_1

WPE_1NA22

WPE_1NB14

DU145

PC3

%correct

RWPE_1

50

0

0

0

0

100

WPE_1NA22

0

41

1

0

0

98

WPE_1NB14

0

0

39

1

1

95

DU145

0

0

4

38

2

86

PC3

0

0

0

0

27

100

Total

50

41

44

39

30

96
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Table 3.3 Classification matrix of 5 cell lines grouped by metastatic potential.
Healthy

Cancerous-lo

Cancerous-hi

%correct

Healthy

50

0

0

100

Cancerous-lo

0

78

5

94

Cancerous-hi

3

2

66

93

Total

53

80

71

95

Canonical Scores Plot

FACTOR(2)

6

2

-2
VAR00001

-6
-6

-2
2
FACTOR(1)

6

Cancerous-hi
Cancerous-lo
Healthy

Figure 3.2 Two-dimensional LDA plot for distinguishing 5 cell lines with different
metastatic potential.
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3.4 USE SL ARRAY TO CLASSIFY DIFFERENT CELL LINES
Previously, SL array which contains SL1 to SL9 on 300 um beads has been used
to discriminate cell lines within each category of prostate, colon, and breast.

A

microscope was used as a way to gain the binding information. This is a useful way to
know the relative binding affinity and selectivity but in the mean time, it’s an energyconsuming process, because the imaging process is a long process. Recently, flow
cytometry has gained our attention. Flow cytometry measures multiple characteristics of
individual particles flowing in single file in a stream of fluid. Light scattering at different
angles can distinguish differences in size and internal complexity.9 The fluorescent
intensity of the beads is quantified on a flow cytometer equipped with a 488 nm
excitation source. It is similar to a microscope to produce an image of the bead, but it
offers "high-throughput" automated quantification of set parameters. So it can analyze a
large quantity of beads in a short period of time, which saves the trouble from
microscope.
The SLs used were SL1-SL9. They were coupled on 10 um polystyrene beads.
RWPE_1, WPE_1NA22, WPE_1NB14, DU145, PC3, HTC116 and HT29 cell lines were
used to study the ability of array to classify different cell lines. The proteins were
secreted proteins, which were isolated from the media. RWPE_1 is an epithelial cell line
from a white male donor that was immortalized with HPV virus and it is a healthy cell
line, which is not invasive10. Neoplastic cells WPE1_NA22 and WPE1_NB14 derived
from RWPE-1 were used

11

. Prostate cancer cell lines DU145 and PC3 cell lines were

also used in the research. They are highly metastatic cell lines. HCT116 and HT29 are 2
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cancerous colon cell lines. They were used to study the ability of SL array to classify cell
lines.
RWPE_1, WPE_1NA22 and WPE_1NB14 cells were cultured in K-SFM with
EGF and BPE. DU145 and PC3 cells were cultured in RPMI media with FBS, Sodium
Bicarbonate, antibiotics, L-glutamine, D-glucose, HEPES, and sodium pyruvate. HCT116
and HT29 were cultured by my lab-mate Tanya Hundal. All the cells were cultured to
around 70% confluent and starved for 48 hours and then secreted proteins were collected
from the media and precipitated with acetone.
Approximately 1 mg of the 10 μm polystyrene beads which contain SLs were
transferred to Eppendorf tubes each and washed with PBS, and pre-blocked with 1mL of
PBS with 10% glycerol (v/v) and 2% BSA (w/v) (blocking buffer). Diluted the FITC
labeled glycoprotein sample to 0.0002 mg/mL in PBS with 2% BSA and 2% EtOH and
then added 1 ml of the protein solution in each Eppendorf tube contained beads and
incubated individually for 12 hours. The beads were then washed with 1 ml PBS with 2%
BSA and 2% EtOH 3 times and resuspended the beads in 1 ml of PBS with 2% BSA and
2% EtOH. Finally, apply the Flowmi 40μm to the end of the 1 mL pipet tip, and filter to
sample through the strainer into a clean 1.5 mL Eppendorf tube. The fluorescence
informations of the sample were quantified by flow cytometer within three hours, which
should take around 7-9 hours using microscope. Using LDA analysis, seven cell lines
were successfully classified with a classification accuracy of 88%. Table 3.4 shows the
cross validation which was used to quantitatively measure the classification accuracy.
The jackknifed classification accuracy was also 88%.
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Table 3.4 Classification matrix of 7 cell lines.

162

WPE_1
NA22
7

WPE_1
NB14
0

6

211

0
0
43
14
9
234

RWEP_1
RWEP_1
WPE_1
NA22
WPE_1
NB14
DU145
PC3
HCT116
HT29
Total

DU145

PC3

HCT116

HT29

%correct

0

46

3

5

73

0

0

8

0

6

91

0

226

0

0

0

0

100

0
4
1
4
227

0
0
0
0
226

197
0
0
0
197

0
169
6
8
237

0
2
198
1
204

0
9
4
206
230

100
74
89
90
88

According to the classification matrix, DU145 and WPE_1NB14 grouped very
well within their categories with 100% classification accuracy. The most misclassified 2
cell lines were PC3 and RWPE_1. It seemed the SL array, which contained SL1-SL9
didn’t classify these 2 cell lines very well. This result has a great difference from the
previous study with SL11 and mutants. SL11 and it mutants classified PC3 and RWPE_1
very well. There is no misclassification between these 2 cell lines. That could indicate
SL11 and its mutants have better ability to discriminate PC3 cell line and RWPE_1 cell
line. So in further study, some SLs in SL11 and its mutants can be added to the array to
see if they can help better discriminate this two cell lines. It’s very likely that they can
help with the discriminant because SL11 is chosen against PC3 out of the dual dye
competitive assay of PC3 and RWPE_1. Therefore, it’s likely to bind to some
glycoproteins only existing in PC3 but not in RWPE_1. So the binding signals for PC3
and RWPE_1 with SL11 or its mutants should be different.
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3.5 CONCLUSIONS AND OUTLOOK
The 300um tentagel beads have shown to have a very good ability to discriminate
cell lines. But the imaging process is a time-consuming process. Now we are trying to
use 10um polystyrene beads, because the fluorescent intensity information of these small
beads can be gained by flow cytometry, which is a "high-throughput" method that can get
the information much faster. The SLs on smaller polystyrene beads are also good at
discriminate cell lines with a classification accuracy of 88%.
Synthetic lectins have a great ability at classifying cell lines with different
metastatic potential. Even just SL11 and its mutants are good to classify cell lines, with a
classification accuracy of 96%. However, the structure-activity relationships of SL11
with glycoproteins are not easy to fully understand. Positively charged arginine may help
with the binding, but the influence is not huge. It’s possible that different portions of SLs
and proteins work together to have the binding affinity instead of a single piece. So
changing only one piece of SL11 does not incur a significant difference in binding.
Further study need to be done to have a better understanding of the binding mechanistics.
3.6 EXPERIMENTAL METHODS
Chemicals
All

amino

acids

and

O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-

phosphate (HBTU) were purchased from Novabiochem Corp. Polystyrene M NH2 (Cat.
No. RTH-9940-PI) was purchased from Peptides International. TentaGel resin (Cat. No.
MB-300-002; loading level 0.25-0.3 mmol/g) was purchased from Rapp Polymere.
Glycoproteins and FITC were purchased from Sigma-Aldrich.
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Microscope Usage
A Leica MZ 16F microscope and a GFP filter set (excitation 450-490 nm; emission filter
500-550 nm) were used to take images, which were analyzed by Adobe Photoshop to
obtain luminosity values afterwards. The luminosity values, which indicate the
fluorescent intensity of the beads tell us the binding intensity. High average luminosity
values means brighter beads, which correspond to strong binders.
General Method for Synthetic Lectin Synthesis
All of the SLs used started with the same first four amino acids, BBRM, before
introducing other amino acids. For SL1-SL9, acylated arginine was used to cap the ends.
For SL11 and its series mutants, no acylation was used. 2-Formylphenylboronic acid was
incorporated onto Diamino-butyric acid, which is a non-natural amino acid. For SL11 and
its mutants, there’s also one 2-Formylphenylboronic acid one the first arginine. Standard
Fmoc/HBTU chemistry was used to extend the peptide backbone. The amino acids had
Fmoc protected amines. Reactive side chains of the amino acids were protected by acidlabile protecting groups. The beads were first soaked in DMF for 10 mins, and preactivated amino acid was added. After tumbling 1 h, the beads were washed with DMF,
methanol and DMF. To remove the Fmoc group, 10 mL 20% piperidine in DMF was
used. The next amino acid was coupled using the same procedure.
Synthesis of SL11 and Its Mutants
TentaGel resin (300 µM; loading capacity 0.25 mmol/g) was used to synthesize SL 11
mutants. After the peptide was synthesized, the N-terminus was not acylated. The ivDde
protecting group of the side-chain amine on Dab was selectively removed by 5%
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hydrazine in DMF for 1 h for 3 times. Then, 2-formylphenylboronic acid was
incorporated.
Incorporation of Phenyl Boronic Acid
The diamino acid ivDde protecting group was removed with 10 mL of 5% (v/v)
hydrazine monohydrate in DMF for 3 times. 8 equivalent of 2-Formylphenyl boronic acid
was dissolved in a mixture of 0.2 mL methanol and 9.8 mL DMF and the liquid was
added to the beads along with activated 3Ǻ molecular sieves and tumbled at 37 ºC
overnight. NaBH4 was added and the cap was open for around 0.5 h to let the gas release
and the resin was tumbled at 37 ºC for 4 h, followed by washing with DMF, methanol,
and DMF. Molecular sieves were removed by adding DCM so the beads would flow
while the molecular sieves were still at the bottom. So the beads can be transferred to
another reaction vessel. After the boronic acid moiety was coupled, 10 mL of 95% TFA,
2.5% water, and 2.5% triisopropysilane was added and the resin was tumbled for 1 h to
deprotect the acid-labile protecting groups. The resin was then washed with DMF,
methanol, and DMF.
Phosphate Buffered Saline (PBS)
Sodium phosphate monobasic (monohydrate) (27.6 g, 200 mmol), sodium phosphate
dibasic (anhydrous) (28.4 g, 200 mmol) and sodium chloride (35.06 g, 600 mmol) were
dissolved in 4 L of DI water and the pH was adjusted to 7.2-7.3 using 3 M NaOH.
Cell Culture
All supplements and media for RWPE_1, WPE_1NA22, WPE_1NB14, DU145, PC3,
HTC116 and HT29 cell lines were ordered. RWPE_1, WPE_1NA22 and WPE_1NB14
cells were cultured in K-SFM with EGF and BPE. DU145 and PC3 cells were cultured in
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RPMI media with carbonate buffer, antibiotics, glutamine, HEPES, and carbonate
pyruvate. HCT116 and HT29 were cultured by my lab-mate Tanya Hundal. The cells
were grown in T75 flasks at 370C. Complete growth medium was pre-warmed by placing
into a warm incubator before using. Complete growth medium was stored at 40C when
not using.
Secreted Protein Preparation
Cells were starved 48 hours before collecting the secreted proteins. After starvation,
media was collected and spun to remove any cells or cell debris. Then a 3 kDa spun tube
was used to filter the media in order to filter out anything smaller than 3 kDa. PBS was
used twice to wash so the proteins were in PBS. Cold acetone was used to precipitate
proteins in the media. The proteins were then washed with acetone one more time and air
dry to get the solid after the removal of excess acetone.
Binding Studies of SLs on Tentagel Resins with Secreted Protein
2mg of each SL was weighed into a centrifuge tube. The SLs were then rinsed with PBS
for 10 minutes for twice. The PBS was removed and 1%BSA in PBS with 10% glycerol
was put in the tubes and incubated for 15 minutes in order to remove non-specific
binding. The solution was then removed. 0.0002mg/ml secreted proteins were added to
the SLs and then tumbled for 6 hours at room temperature under aluminum foil. After
tumbling the beads were washed three times with PBS and imaged with a fluorescence
microscope, Leica MZ 16F, using a GFP filter set.
Binding Studies of SLs on Polystyrene Beads with Secreted Protein
Approximately 1 mg of the 10μm polystyrene beads which contain SL1 to SL9 were
transferred to Eppendorf tubes each and washed with PBS twice, and pre-blocked with
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1mL of PBS with 10% glycerol (v/v) and 2% BSA (w/v) (blocking buffer). Diluted the
FITC labeled glycoprotein sample to 0.0002 mg/mL in PBS with 2% BSA and 2% EtOH
and then added 1 ml of the diluted protein solution in each Eppendorf tube contained
beads and incubated individually for 12 hours. The beads were then washed with 1 ml
PBS with 2% BSA and 2% EtOH 3 times and resuspended the beads in 1 ml of PBS with
2% BSA and 2% EtOH. Finally, applied the Flowmi 40μm to the end of the 1mL pipet
tip, and filtered to sample through the strainer into a clean 1.5mL Eppendorf tube. The
fluorescence information of the sample were quantified by flow cytometry.
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CHAPTER 4
CONCLUSIONS AND FUTURE WORK
4.0 SUMMARY OF WORK
Prostate cancer is now the second leading cause of cancer death in American men
according to American Cancer Society. There have been diagnostics for prostate cancer.
Main methods include PSA (Prostate specific antigen) blood test, digital rectal exam,
biopsy, etc.1 However, these diagnostics are not perfect. For instance, biopsy is a painful
process for patients and may cause bleeding and infection. So a new prostate cancer
diagnostic is in great need. Glycosylation patterns can provide information about diease.2
Glycans and glycoproteins on the cell surface will be over, under or neo-expressed when
the cancer occurs.3 Different cancer types may have different glycosylation pattern.
Therefore the different glycosylation patterns can be used for cancer diagnosis.4-6 In order
to study and use these glycosylation patterns, a synthetic lectin array has been developed.
Synthetic lectin array contains 9 SLs and have showed great ability to classify cell lines.
Synthetic lectins use the boronic acid-diol interaction, which is a kind of covalent
yet reversible interaction. They have many advantages like non-toxic, low cost and stable.
The design of synthetic lectins also guarantee the diversity of the synthetic lectins since
there are many kinds of natural or non-natural amino acid that we can use. This thesis
focused on the structure-activity relationships of SL11 with purified glycoproteins, cell
membrane proteins and secreted proteins. It’s interesting that the replacement of arginine
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to alanine can decrease the binding affinity no matter what kind of proteins used. That is
likely due to the negatively charged glycan moieties on the glycoprotein like to interact
with positively charged arginines. Therefore arginine can help increase the binding
affinity. However, charge does not hugely influence the binding affinity with prostate cell
proteins compared with purified glycoproteins. This might indicate that the negatively
charged glycans are not so abundant in prostate cell lines compared with purified
glycoproteins. But positively charged arginine is more important in the binding of SL
with highly metastatic cell lines compared with lowly metastatic cell lines or healthy cell
lines. That indicates there might be an over-expression of sialic acid group in highly
metastatic cell lines.
The 300 um beads have shown to have a very good ability to discriminant cell
lines. But the imaging process is a time-consuming process. Recently, 10 um beads and
flow cytometry have caught our eyes. Flow cytometry method measures multiple
characteristics of individual particles flowing in single file in a stream of fluid. Light
scattering at different angles can distinguish differences in size and internal complexity.7
The fluorescent intensities of the beads are quantified on a flow cytometer equipped with
a 488 nm excitation source. It offers "high-throughput" automated quantification of set
parameter so that can get the information so much faster. The incubation of SL array on
smaller polystyrene beads with 7 cell lines was done. The 7 cell lines used were HCT116,
HT29, RWPE-1, WPE_1NA22, WPE_1NB14, DU145, and PC3.

The SLs on

polystyrene beads discriminated 7 cell lines with a classification accuracy of 88%. The
cell lines that were most misclassified were PC3 and RWPE_1 cell lines. Using SL11 and
its mutants had a classification accuracy of 96% in classifying 5 prostate cell lines. PC3
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and RWPE_1 were not misclassified with each other. So in the near future, SL11 can be
added in the SL array in order to increase the classification accuracy.
4.1 THE FUTURE OF SL SENSOR ARRAYS
The mechanistic details of the SL-protein binding are still not clearly figured out.
But it’s very possible that positive charge can help increase the binding affinity between
SL and negatively charged glycans. So in further study, more charged amino acid point
mutations need to be done to get SLs that have better binding affinity with glycoproteins
and better discriminant of cell lines. With the help of flow cytometry, this study can be
done much faster.
The SL array has been used to classify many cell lines. Since we have tried to use
10um beads and flow cytometry to classify cell lines, we need to compare the data from
flow cytometry with the data from microscope to make sure they are consistent with each
other. Also, more cell lines need to be tested.
It’s advantageous to use secreted proteins instead of membrane proteins because
of the ease and cheaper price in collecting secreted proteins. Secreted proteins can better
represent the protein in blood while membrane proteins are more like proteins in tissue. If
there will be a more accurate diagnostic using blood, it will reduce a lot of pains and
trouble doing prostate biopsy to patients. Since flow cytometry has been used, we can
also try to do the whole cell screening. So in further study, the SLs can be cleaved from
the beads and incubate with cells individually. By screening the whole cells, we can still
get a pattern from the SL array. Since there will be more information on cells compared
with membrane or secreted proteins, it’s also a good alternative to screen the whole cells.
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It’s not necessary to always use SL1-SL 9 as the synthetic lectin array. Some SLs
in the array may have great binding affinity with many cell proteins. Therefore they are
not capable of helping classify different cell lines. So we can exclude some of them from
the array.

We have begun to choose SLs against cell lines. In the future, we can

gradually choose more interesting SLs from the screening of SL library incubated with
cell proteins instead of purified glycoproteins. As we find more interesting SLs, we can
also add them in the array, in order to get better classification accuracy. As we do more
research, we can gradually use more human tissues or blood instead of just using cell
lines.
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